Methamphetamine toxicity and messengers of death
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abekawa, 1994, Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens, Brain Res., 643, 276, 10.1016/0006-8993(94)90033-7
Achat-Mendes, 2005, Differential effects of amphetamines-induced neurotoxicity on appetitive and aversive Pavlovian conditioning in mice, Neuropsychopharmacology, 30, 1128, 10.1038/sj.npp.1300675
Achat-Mendes, 2007, Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists, Neuropsychopharmacology, 32, 531, 10.1038/sj.npp.1301119
Acikgoz, 1998, Methamphetamine causes lipid peroxidation and an increase in superoxide dismutase activity in the rat striatum, Brain Res., 813, 200, 10.1016/S0006-8993(98)01020-8
Albers, 1995, Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents, J. Pharmacol. Exp. Ther., 275, 1104
Albertson, 1999, Methamphetamine and the expanding complications of amphetamines, West. J. Med., 170, 214
Ali, 1998, Effects of 7-nitroindazole, an NOS inhibitor on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in mice, Ann. N. Y. Acad. Sci., 844, 122, 10.1111/j.1749-6632.1998.tb08227.x
Ali, 1996, Methamphetamine-induced dopaminergic toxicity in mice. Role of environmental temperature and pharmacological agents, Ann. N. Y. Acad. Sci., 801, 187, 10.1111/j.1749-6632.1996.tb17441.x
Anderson, 2006, Methamphetamine-induced selective dopaminergic neurotoxicity is accompanied by an increase in striatal nitrate in the mouse, Ann. N. Y. Acad. Sci., 1074, 225, 10.1196/annals.1369.021
Ando, 1985, Sensitivity changes to dopaminergic agents in fine motor control of rhesus monkeys after repeated methamphetamine administration, Pharmacol. Biochem. Behav., 22, 737, 10.1016/0091-3057(85)90522-2
Angulo, 2004, Antagonists of the neurokinin-1 or dopamine D1 receptors confer protection from methamphetamine on dopamine terminals of the mouse striatum, Ann. N. Y. Acad. Sci., 1025, 171, 10.1196/annals.1316.022
Armstrong, 2004, The neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine on serotonin, dopamine, and GABA-ergic terminals: an in-vitro autoradiographic study in rats, Neurotoxicology, 25, 905, 10.1016/j.neuro.2004.06.003
Aron, 2007, Location, location: using functional magnetic resonance imaging to pinpoint brain differences relevant to stimulant use, Addiction, 102, 33, 10.1111/j.1360-0443.2006.01778.x
Asanuma, 2000, Direct interactions of methamphetamine with the nucleus., Brain Res. Mol. Brain Res., 80, 237, 10.1016/S0169-328X(00)00128-5
Asanuma, 2003, Methamphetamine-induced neurotoxicity in mouse brain is attenuated by ketoprofen, a non-steroidal anti-inflammatory drug, Neurosci. Lett., 352, 13, 10.1016/j.neulet.2003.08.015
Asanuma, 2004, Specific gene expression and possible involvement of inflammation in methamphetamine-induced neurotoxicity, Ann. N. Y. Acad. Sci., 1025, 69, 10.1196/annals.1316.009
Australian Institute of Health and Welfare, 2005. 2004 National Drug Strategy Household Survey: Detailed Findings. AIHW cat. no. PHE 66. Drug Statistics Series no. 16, AIHW, Canberra.
Axt, 1991, Immunocytochemical evidence for methamphetamine-induced serotonergic axon loss in the rat brain, Synapse, 9, 302, 10.1002/syn.890090405
Axt, 1990, alpha-Methyl-p-tyrosine pretreatment partially prevents methamphetamine-induced endogenous neurotoxin formation, Brain Res., 515, 269, 10.1016/0006-8993(90)90606-C
Bae, 2006, Increased white matter hyperintensities in male methamphetamine abusers, Drug Alcohol Depend., 81, 83, 10.1016/j.drugalcdep.2005.05.016
Bakhit, 1981, Long-term effects of methamphetamine on the synthesis and metabolism of 5-hydroxytryptamine in various regions of the rat brain, Neuropharmacology, 20, 1135, 10.1016/0028-3908(81)90053-8
Baldwin, 1993, Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine, Br. J. Pharmacol., 108, 590, 10.1111/j.1476-5381.1993.tb12847.x
Barr, 2006, The need for speed: an update on methamphetamine addiction, J. Psychiatry Neurosci., 31, 301
Barrett, 2001, A murine dopamine neuron-specific cDNA library and microarray: increased COX1 expression during methamphetamine neurotoxicity, Neurobiol. Dis., 8, 822, 10.1006/nbdi.2001.0423
Barzilai, 2007, The contribution of the DNA damage response to neuronal viability, Antioxid. Redox Signal., 9, 211, 10.1089/ars.2007.9.211
Battaglia, 2002, Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity, J. Neurosci., 22, 2135, 10.1523/JNEUROSCI.22-06-02135.2002
Betts, 2002, Analysis of methamphetamine-induced changes in the expression of integrin family members in the cortex of wild-type and c-fos knockout mice, Neurotox. Res., 4, 617, 10.1080/1029842021000045453
Bittner, 1981, Effects of a high-dose treatment of methamphetamine on caudate dopamine and anorexia in rats, Pharmacol. Biochem. Behav., 14, 481, 10.1016/0091-3057(81)90306-3
Block, 2007, Microglia-mediated neurotoxicity: uncovering the molecular mechanisms, Nat. Rev. Neurosci., 8, 57, 10.1038/nrn2038
Bowyer, 2006, High doses of methamphetamine that cause disruption of the blood–brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus, Synapse, 60, 521, 10.1002/syn.20324
Bowyer, 1992, The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum, J. Pharmacol. Exp. Ther., 260, 817
Bowyer, 1994, Further studies of the role of hyperthermia in methamphetamine neurotoxicity, J. Pharmacol. Exp. Ther., 268, 1571
Bowyer, 2001, Phenobarbital and dizocilpine can block methamphetamine-induced neurotoxicity in mice by mechanisms that are independent of thermoregulation, Brain Res., 919, 179, 10.1016/S0006-8993(01)03051-7
Bowyer, 2008, Neurotoxic-related changes in tyrosine hydroxylase, microglia, myelin, and the blood–brain barrier in the caudate–putamen from acute methamphetamine exposure, Synapse, 62, 193, 10.1002/syn.20478
Brecht, 2004, Methamphetamine use behaviors and gender differences, Addict. Behav., 29, 89, 10.1016/S0306-4603(03)00082-0
Breckenridge, 2004, Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases, Curr. Opin. Cell Biol., 16, 647, 10.1016/j.ceb.2004.09.009
Broening, 2005, Interactions of dopamine D1 and D2 receptor antagonists with d-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions, Synapse, 56, 84, 10.1002/syn.20130
Brown, 2005, Methamphetamine-induced inhibition of mitochondrial complex II: roles of glutamate and peroxynitrite, J. Neurochem., 95, 429, 10.1111/j.1471-4159.2005.03379.x
Burrows, 2000, Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration, Eur. J. Pharmacol., 398, 11, 10.1016/S0014-2999(00)00264-8
Cadet, 1998, Free radicals and the pathobiology of brain dopamine systems, Neurochem. Int., 32, 117, 10.1016/S0197-0186(97)00031-4
Cadet, 2007, Interactions of HIV and methamphetamine: cellular and molecular mechanisms of toxicity potentiation, Neurotox. Res., 12, 181, 10.1007/BF03033915
Cadet, 1994, Involvement of oxygen-based radicals in methamphetamine-induced neurotoxicity: evidence from the use of CuZnSOD transgenic mice, Ann. N. Y. Acad. Sci., 738, 388, 10.1111/j.1749-6632.1994.tb21827.x
Cadet, 1994, Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice, J. Neurochem., 62, 380, 10.1046/j.1471-4159.1994.62010380.x
Cadet, 2001, Temporal profiling of methamphetamine-induced changes in gene expression in the mouse brain: evidence from cDNA array, Synapse, 41, 40, 10.1002/syn.1058
Cadet, 2002, Distinct gene expression signatures in the striata of wild-type and heterozygous c-fos knockout mice following methamphetamine administration: evidence from cDNA array analyses, Synapse, 44, 211, 10.1002/syn.10074
Cadet, 2005, Methamphetamine-induced neuronal apoptosis involves the activation of multiple death pathways, Neurotox. Res., 8, 199, 10.1007/BF03033973
Cadet, 2007, Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms, Neurotox. Res., 11, 183, 10.1007/BF03033567
Cadet, 1997, Methamphetamine induces apoptosis in immortalized neural cells: protection by the proto-oncogene, bcl-2, Synapse, 25, 176, 10.1002/(SICI)1098-2396(199702)25:2<176::AID-SYN8>3.0.CO;2-9
Caldwell, 1976, The metabolism of amphetamines in mammals, Drug Metab. Rev., 5, 219, 10.3109/03602537609029979
Callahan, 2001, Inhibitors of Na(+)/H(+) and Na(+)/Ca(2+) exchange potentiate methamphetamine-induced dopamine neurotoxicity: possible role of ionic dysregulation in methamphetamine neurotoxicity, J. Neurochem., 77, 1348, 10.1046/j.1471-4159.2001.00341.x
2005
Cappon, 2000, Time-course of methamphetamine-induced neurotoxicity in rat caudate–putamen after single-dose treatment, Brain Res., 863, 106, 10.1016/S0006-8993(00)02107-7
Castino, 2008, Suppression of autophagy precipitates neuronal cell death following low doses of methamphetamine, J. Neurochem., 106, 1426, 10.1111/j.1471-4159.2008.05488.x
Chang, 2002, Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users, Psychiatry Res., 114, 65, 10.1016/S0925-4927(02)00004-5
Chang, 2007, Structural and metabolic brain changes in the striatum associated with methamphetamine abuse, Addiction, 102, 16, 10.1111/j.1360-0443.2006.01782.x
Chapman, 2001, Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine, J. Pharmacol. Exp. Ther., 296, 520
Chen, 2007, Methamphetamine downregulates peroxiredoxins in rat pheochromocytoma cells, Biochem. Biophys. Res. Commun., 354, 96, 10.1016/j.bbrc.2006.12.138
Chipana, 2008, Memantine protects against amphetamine derivatives-induced neurotoxic damage in rodents, Neuropharmacology, 54, 1254, 10.1016/j.neuropharm.2008.04.003
Choi, 2004, Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses, Brain Res. Brain Res. Rev., 44, 65, 10.1016/j.brainresrev.2003.08.007
Choi, 2002, Methamphetamine-induced apoptosis in a CNS-derived catecholaminergic cell line, Mol. Cells, 13, 221, 10.1016/S1016-8478(23)15026-6
Chuang, 2004, Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?, Crit. Rev. Neurobiol., 16, 83, 10.1615/CritRevNeurobiol.v16.i12.90
Commins, 1986, alpha-Methyltyrosine blocks methylamphetamine-induced degeneration in the rat somatosensory cortex, Brain Res., 365, 15, 10.1016/0006-8993(86)90717-1
Cubells, 1994, Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress, J. Neurosci., 14, 2260, 10.1523/JNEUROSCI.14-04-02260.1994
Cunha-Oliveira, 2008, Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs, Brain Res. Rev., 58, 192, 10.1016/j.brainresrev.2008.03.002
D'Almeida, 1995, Antioxidant defense in rat brain after chronic treatment with anorectic drugs, Toxicol. Lett., 81, 101, 10.1016/0378-4274(95)03408-0
Dalton, 1999, Regulation of gene expression by reactive oxygen, Annu. Rev. Pharmacol. Toxicol., 39, 67, 10.1146/annurev.pharmtox.39.1.67
Danaceau, 2007, Persistence of tolerance to methamphetamine-induced monoamine deficits, Eur. J. Pharmacol., 559, 46, 10.1016/j.ejphar.2006.11.045
Darke, 2008, Major physical and psychological harms of methamphetamine use, Drug Alcohol Rev., 27, 253, 10.1080/09595230801923702
Dascombe, 1989, Pyrogenic and thermogenic effects of interleukin 1 beta in the rat, Am. J. Physiol., 256, E7
Davidson, 2001, Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment, Brain Res. Brain Res. Rev., 36, 1, 10.1016/S0165-0173(01)00054-6
Deng, 2000, Methamphetamine-induced apoptosis is attenuated in the striata of copper–zinc superoxide dismutase transgenic mice, Brain Res. Mol. Brain Res., 83, 121, 10.1016/S0169-328X(00)00169-8
Deng, 1999, Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity, J. Neurosci., 19, 10107, 10.1523/JNEUROSCI.19-22-10107.1999
Deng, 2001, Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method, Brain Res. Mol. Brain Res., 93, 64, 10.1016/S0169-328X(01)00184-X
Deng, 2002, Methamphetamine induces apoptosis in an immortalized rat striatal cell line by activating the mitochondrial cell death pathway, Neuropharmacology, 42, 837, 10.1016/S0028-3908(02)00034-5
Deng, 2002, Mice with partial deficiency of c-Jun show attenuation of methamphetamine-induced neuronal apoptosis, Mol. Pharmacol., 62, 993, 10.1124/mol.62.5.993
Deng, 2007, Methamphetamine administration causes death of dopaminergic neurons in the mouse olfactory bulb, Biol. Psychiatry, 61, 1235, 10.1016/j.biopsych.2006.09.010
De Vito, 1989, Methamphetamine-induced neuronal damage: a possible role for free radicals, Neuropharmacology, 28, 1145, 10.1016/0028-3908(89)90130-5
Di Monte, 1996, Role of nitric oxide in methamphetamine neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase, J. Neurochem., 67, 2443, 10.1046/j.1471-4159.1996.67062443.x
Droin, 2003, Egr family members regulate nonlymphoid expression of Fas ligand, TRAIL, and tumor necrosis factor during immune responses, Mol. Cell. Biol., 23, 7638, 10.1128/MCB.23.21.7638-7647.2003
Dye, 2006, Recipe for disaster: Mexican methamphetamine, J. Med. Toxicol., 2, 81, 10.1007/BF03161177
Eisch, 1998, Methamphetamine neurotoxicity: dissociation of striatal dopamine terminal damage from parietal cortical cell body injury, Synapse, 30, 433, 10.1002/(SICI)1098-2396(199812)30:4<433::AID-SYN10>3.0.CO;2-O
Eisch, 1992, Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamine, Brain Res., 598, 321, 10.1016/0006-8993(92)90201-J
Ernst, 2000, Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study, Neurology, 54, 1344, 10.1212/WNL.54.6.1344
Escubedo, 1998, Microgliosis and down-regulation of adenosine transporter induced by methamphetamine in rats, Brain Res., 814, 120, 10.1016/S0006-8993(98)01065-8
Escubedo, 2005, Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of alpha7 nicotinic receptors, J. Pharmacol. Exp. Ther., 315, 658, 10.1124/jpet.105.089748
2007
Eyerman, 2005, Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum, J. Pharmacol. Exp. Ther., 312, 160, 10.1124/jpet.104.072264
Eyerman, 2007, A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine, J. Neurochem., 103, 1219, 10.1111/j.1471-4159.2007.04837.x
Fantegrossi, 2008, A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse, Neuroscience, 151, 533, 10.1016/j.neuroscience.2007.11.007
Farfel, 1995, Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan, J. Pharmacol. Exp. Ther., 272, 868
Farfel, 1992, The N-methyl-d-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine, Brain Res., 595, 121, 10.1016/0006-8993(92)91460-V
Feng, 2001, Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway, Mol. Endocrinol., 15, 32, 10.1210/me.15.1.32
Finnegan, 1982, Altered sensitivity to d-methylamphetamine, apomorphine, and haloperidol in rhesus monkeys depleted of caudate dopamine by repeated administration of d-methylamphetamine, Psychopharmacology (Berl), 77, 43, 10.1007/BF00436098
Fishel, 2007, DNA repair in neurons: so if they don't divide what's to repair?, Mutat. Res., 614, 24, 10.1016/j.mrfmmm.2006.06.007
Fitzmaurice, 2006, Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetamine, J. Pharmacol. Exp. Ther., 319, 703, 10.1124/jpet.106.109173
Fleckenstein, 1997, Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration, J. Pharmacol. Exp. Ther., 283, 281
Fornai, 2003, Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition, J. Neurosci., 23, 8955, 10.1523/JNEUROSCI.23-26-08955.2003
Fornai, 2004, Similarities between methamphetamine toxicity and proteasome inhibition, Ann. N. Y. Acad. Sci., 1025, 162, 10.1196/annals.1316.021
Fornai, 2004, Methamphetamine produces neuronal inclusions in the nigrostriatal system and in PC12 cells, J. Neurochem., 88, 114, 10.1046/j.1471-4159.2003.02137.x
Fornai, 2005, Occurrence of neuronal inclusions combined with increased nigral expression of alpha-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice, Brain Res. Bull., 65, 405, 10.1016/j.brainresbull.2005.02.022
Fornai, 2008, Involvement of dopamine receptors and beta-arrestin in metamphetamine-induced inclusions formation in PC12 cells, J. Neurochem., 105, 1939, 10.1111/j.1471-4159.2008.05284.x
Friedman, 1998, Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity, Pharmacol. Biochem. Behav., 61, 35, 10.1016/S0091-3057(98)00066-5
Fukami, 2004, Effect of antioxidant N-acetyl-l-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine, Brain Res., 1016, 90, 10.1016/j.brainres.2004.04.072
Fukui, 1989, Selective reduction of serotonin immunoreactivity in some forebrain regions of rats induced by acute methamphetamine treatment; quantitative morphometric analysis by serotonin immunocytochemistry, Brain Res., 482, 198, 10.1016/0006-8993(89)90562-3
Fukumura, 1998, A single dose model of methamphetamine-induced neurotoxicity in rats: effects on neostriatal monoamines and glial fibrillary acidic protein, Brain Res., 806, 1, 10.1016/S0006-8993(98)00656-8
Fuller, 1992, Protection against amphetamine-induced neurotoxicity toward striatal dopamine neurons in rodents by LY274614, an excitatory amino acid antagonist, Neuropharmacology, 31, 1027, 10.1016/0028-3908(92)90104-W
Fumagalli, 1998, Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter, J. Neurosci., 18, 4861, 10.1523/JNEUROSCI.18-13-04861.1998
Fumagalli, 1999, Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice, J. Neurosci., 19, 2424, 10.1523/JNEUROSCI.19-07-02424.1999
Gettig, 2006, Methamphetamine: putting the brakes on speed, J. Sch. Nurs., 22, 66, 10.1177/105984050602200202
Gibb, 1979, Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity, Naunyn Schmiedebergs Arch. Pharmacol., 310, 185, 10.1007/BF00500283
Gilcrease, 2007, Integrin signaling in epithelial cells, Cancer Lett., 247, 1, 10.1016/j.canlet.2006.03.031
Giovanni, 1995, Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine, J. Neurochem., 64, 1819, 10.1046/j.1471-4159.1995.64041819.x
Gluck, 2001, Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment, J. Neurochem., 79, 152, 10.1046/j.1471-4159.2001.00549.x
Golembiowska, 2003, Neuroprotective action of MPEP, a selective mGluR5 antagonist, in methamphetamine-induced dopaminergic neurotoxicity is associated with a decrease in dopamine outflow and inhibition of hyperthermia in rats, Neuropharmacology, 45, 484, 10.1016/S0028-3908(03)00209-0
Gonzalez, 2004, Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure, Drug Alcohol Depend., 76, 181, 10.1016/j.drugalcdep.2004.04.014
Gonzales, 2008, An emerging problem: methamphetamine abuse among treatment seeking youth, Subst. Abuse, 29, 71, 10.1080/08897070802093312
Gorlach, 2006, The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control, Antioxid. Redox Signal., 8, 1391, 10.1089/ars.2006.8.1391
Graham, 2008, Differential neurochemical consequences of an escalating dose-binge regimen followed by single-day multiple-dose methamphetamine challenges, J. Neurochem., 105, 1873, 10.1111/j.1471-4159.2008.05269.x
Green, 1992, The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: evidence for the protective effect of chlormethiazole, Neuropharmacology, 31, 315, 10.1016/0028-3908(92)90062-T
Guilarte, 2003, Methamphetamine-induced deficits of brain monoaminergic neuronal markers: distal axotomy or neuronal plasticity, Neuroscience, 122, 499, 10.1016/S0306-4522(03)00476-7
Gunasekar, 1995, NMDA receptor activation produces concurrent generation of nitric oxide and reactive oxygen species: implication for cell death, J. Neurochem., 65, 2016, 10.1046/j.1471-4159.1995.65052016.x
Gygi, 1996, Mechanisms for tolerance to methamphetamine effects, Neuropharmacology, 35, 751, 10.1016/0028-3908(96)84647-8
Halladay, 2003, Relationship between methamphetamine-induced dopamine release, hyperthermia, self-injurious behaviour and long term dopamine depletion in BALB/c and C57BL/6 mice, Pharmacol. Toxicol., 93, 33, 10.1034/j.1600-0773.2003.930105.x
Harold, 2000, Methamphetamine selectively alters brain glutathione, Eur. J. Pharmacol., 400, 99, 10.1016/S0014-2999(00)00392-7
Hashimoto, 2004, Protective effects of N-acetyl-l-cysteine on the reduction of dopamine transporters in the striatum of monkeys treated with methamphetamine, Neuropsychopharmacology, 29, 2018, 10.1038/sj.npp.1300512
He, 2004, Neuroprotective effects of olanzapine on methamphetamine-induced neurotoxicity are associated with an inhibition of hyperthermia and prevention of Bcl-2 decrease in rats, Brain Res., 1018, 186, 10.1016/j.brainres.2004.05.060
Hirata, 1996, Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice, Brain Res., 714, 95, 10.1016/0006-8993(95)01502-7
Hogan, 2003, Transcriptional regulation by calcium, calcineurin, and NFAT, Genes Dev., 17, 2205, 10.1101/gad.1102703
Hom, 1997, Elevated expression of glutathione peroxidase in PC12 cells results in protection against methamphetamine but not MPTP toxicity, Brain Res. Mol. Brain Res., 46, 154, 10.1016/S0169-328X(96)00296-3
Homer, 2008, Methamphetamine abuse and impairment of social functioning: a review of the underlying neurophysiological causes and behavioral implications, Psychol. Bull., 134, 301, 10.1037/0033-2909.134.2.301
Hotchkiss, 1980, Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain, J. Pharmacol. Exp. Ther, 214, 257
Hotchkiss, 1979, The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities, Life Sci., 25, 1373, 10.1016/0024-3205(79)90414-4
Hsu, 2006, Brain cooling causes attenuation of cerebral oxidative stress, systemic inflammation, activated coagulation, and tissue ischemia/injury during heatstroke, Shock, 26, 210, 10.1097/01.shk.0000223124.49265.10
Imam, 2001, Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts, Ann. N. Y. Acad. Sci., 939, 366, 10.1111/j.1749-6632.2001.tb03646.x
Imam, 2001, Methamphetamine-induced alteration in striatal p53 and bcl-2 expressions in mice, Brain Res. Mol. Brain Res., 91, 174, 10.1016/S0169-328X(01)00139-5
Imam, 2001, Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper–zinc superoxide dismutase, J. Neurochem., 76, 745, 10.1046/j.1471-4159.2001.00029.x
Imam, 2005, Nitric oxide mediates increased susceptibility to dopaminergic damage in Nurr1 heterozygous mice, FASEB J., 19, 1441, 10.1096/fj.04-3362com
Ito, 2008, Hyperthermic and lethal effects of methamphetamine: roles of dopamine D1 and D2 receptors, Neurosci. Lett., 438, 327, 10.1016/j.neulet.2008.04.034
Itzhak, 1996, The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo, J. Neurochem., 67, 1770, 10.1046/j.1471-4159.1996.67041770.x
Itzhak, 2006, Role of nitrergic system in behavioral and neurotoxic effects of amphetamine analogs, Pharmacol. Ther., 109, 246, 10.1016/j.pharmthera.2005.08.004
Itzhak, 1998, Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity, J. Pharmacol. Exp. Ther., 284, 1040
Itzhak, 2000, nNOS inhibitors attenuate methamphetamine-induced dopaminergic neurotoxicity but not hyperthermia in mice, Neuroreport, 11, 2943, 10.1097/00001756-200009110-00022
Iversen, 2006, Neurotransmitter transporters and their impact on the development of psychopharmacology, Br. J. Pharmacol., 147, S82, 10.1038/sj.bjp.0706428
Iwashita, 2004, A new poly(ADP-ribose) polymerase inhibitor, FR261529 [2-(4-chlorophenyl)-5-quinoxalinecarboxamide], ameliorates methamphetamine-induced dopaminergic neurotoxicity in mice, J. Pharmacol. Exp. Ther., 310, 1114, 10.1124/jpet.104.068932
Iwazaki, 2006, Protein expression profile in the striatum of acute methamphetamine-treated rats, Brain Res., 1097, 19, 10.1016/j.brainres.2006.04.052
Jayanthi, 1998, Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice, Ann. N. Y. Acad. Sci., 844, 92, 10.1111/j.1749-6632.1998.tb08224.x
Jayanthi, 2001, Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex, FASEB J., 15, 1745, 10.1096/fj.01-0025com
Jayanthi, 2002, Methamphetamine causes coordinate regulation of Src, Cas, Crk, and the Jun N-terminal kinase–Jun pathway, Mol. Pharmacol., 61, 1124, 10.1124/mol.61.5.1124
Jayanthi, 2004, Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades, FASEB J., 18, 238, 10.1096/fj.03-0295com
Jayanthi, 2005, Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis, Proc. Natl. Acad. Sci. U. S. A., 102, 868, 10.1073/pnas.0404990102
Jeng, 2006, Prostaglandin H synthase-catalyzed bioactivation of amphetamines to free radical intermediates that cause CNS regional DNA oxidation and nerve terminal degeneration, FASEB J., 20, 638, 10.1096/fj.05-5271com
Jeng, 2005, Methamphetamine-enhanced embryonic oxidative DNA damage and neurodevelopmental deficits, Free Radic. Biol. Med., 39, 317, 10.1016/j.freeradbiomed.2005.03.015
Jimenez, 2004, Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells, Toxicol. Appl. Pharmacol., 196, 223, 10.1016/j.taap.2003.12.017
Johnson-Davis, 2003, The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity, Eur. J. Pharmacol., 482, 151, 10.1016/j.ejphar.2003.09.063
Johnson-Davis, 2004, Alterations in vesicular dopamine uptake contribute to tolerance to the neurotoxic effects of methamphetamine, J. Pharmacol. Exp. Ther., 309, 578, 10.1124/jpet.103.062695
Kadota, 2004, Neurotoxic morphological changes induced in the medial prefrontal cortex of rats behaviorally sensitized to methamphetamine, Arch. Histol. Cytol., 67, 241, 10.1679/aohc.67.241
Kanthasamy, 2006, Methamphetamine induces autophagy and apoptosis in a mesencephalic dopaminergic neuronal culture model: role of cathepsin-D in methamphetamine-induced apoptotic cell death, Ann. N. Y. Acad. Sci., 1074, 234, 10.1196/annals.1369.022
Kawasaki, 2006, Protective effect of the radical scavenger edaravone against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum, Eur. J. Pharmacol., 542, 92, 10.1016/j.ejphar.2006.05.012
Keller, 2000, Dopamine induces proteasome inhibition in neural PC12 cell line, Free Radic. Biol. Med., 29, 1037, 10.1016/S0891-5849(00)00412-3
Kil, 1996, Brain temperature alters hydroxyl radical production during cerebral ischemia/reperfusion in rats, J. Cereb. Blood Flow Metab., 16, 100, 10.1097/00004647-199601000-00012
Kim, 2006, Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease, Exp. Mol. Med., 38, 333, 10.1038/emm.2006.40
Kish, 2008, Brain serotonin transporter in human methamphetamine users, Psychopharmacology (Berl)
Kita, 1995, Effects of pargyline and pyrogallol on the methamphetamine-induced dopamine depletion, Mol. Chem. Neuropathol., 24, 31, 10.1007/BF03160110
Kita, 1998, Methamphetamine-induced neurotoxicity in BALB/c, DBA/2N and C57BL/6N mice, Neuropharmacology, 37, 1177, 10.1016/S0028-3908(98)00106-3
Kita, 1999, Hydroxyl radical formation following methamphetamine administration to rats, Pharmacol. Toxicol., 85, 133, 10.1111/j.1600-0773.1999.tb00080.x
Kitamura, 2007, Immunohistochemical investigation of dopaminergic terminal markers and caspase-3 activation in the striatum of human methamphetamine users, Int. J. Legal Med., 121, 163, 10.1007/s00414-006-0087-9
Kiyatkin, 2007, Brain edema and breakdown of the blood–brain barrier during methamphetamine intoxication: critical role of brain hyperthermia, Eur. J. Neurosci., 26, 1242, 10.1111/j.1460-9568.2007.05741.x
Kobeissy, 2008, Psychoproteomic analysis of rat cortex following acute methamphetamine exposure, J. Proteome Res., 7, 1971, 10.1021/pr800029h
Kogan, 1976, Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels, Eur. J. Pharmacol., 36, 363, 10.1016/0014-2999(76)90090-X
Kondo, 1994, Bromocriptine scavenges methamphetamine-induced hydroxyl radicals and attenuates dopamine depletion in mouse striatum, Ann. N. Y. Acad. Sci., 738, 222, 10.1111/j.1749-6632.1994.tb21807.x
Kroemer, 2007, Mitochondrial membrane permeabilization in cell death, Physiol. Rev., 87, 99, 10.1152/physrev.00013.2006
Kuczenski, 2007, Escalating dose-multiple binge methamphetamine exposure results in degeneration of the neocortex and limbic system in the rat, Exp. Neurol., 207, 42, 10.1016/j.expneurol.2007.05.023
Kuhn, 1999, Tyrosine hydroxylase is inactivated by catechol-quinones and converted to a redox-cycling quinoprotein: possible relevance to Parkinson's disease, J. Neurochem., 73, 1309, 10.1046/j.1471-4159.1999.0731309.x
Kuhn, 2008, Dopamine disposition in the presynaptic process regulates the severity of methamphetamine-induced neurotoxicity, Ann. N. Y. Acad. Sci., 1139, 118, 10.1196/annals.1432.026
Ladenheim, 2000, Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6, Mol. Pharmacol., 58, 1247, 10.1124/mol.58.6.1247
Lafon-Cazal, 1993, NMDA-dependent superoxide production and neurotoxicity, Nature, 364, 535, 10.1038/364535a0
Larsen, 2002, Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis, J. Neurosci., 22, 8951, 10.1523/JNEUROSCI.22-20-08951.2002
LaVoie, 1999, Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine, J. Neurosci., 19, 1484, 10.1523/JNEUROSCI.19-04-01484.1999
LaVoie, 2004, Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity, Exp. Neurol., 187, 47, 10.1016/j.expneurol.2004.01.010
Lazzeri, 2007, Mechanisms involved in the formation of dopamine-induced intracellular bodies within striatal neurons, J. Neurochem., 101, 1414, 10.1111/j.1471-4159.2006.04429.x
Lazzeri, 2006, In PC12 cells neurotoxicity induced by methamphetamine is related to proteasome inhibition, Ann. N. Y. Acad. Sci., 1074, 174, 10.1196/annals.1369.017
Leon, 2002, Invited review: cytokine regulation of fever: studies using gene knockout mice, J. Appl. Physiol., 92, 2648, 10.1152/japplphysiol.01005.2001
Li, 1993, DNA damage resulting from the oxidation of hydroquinone by copper: role for a Cu(II)/Cu(I) redox cycle and reactive oxygen generation, Carcinogenesis, 14, 1303, 10.1093/carcin/14.7.1303
Li, 2008, Proteomic profiling of proteins associated with methamphetamine-induced neurotoxicity in different regions of rat brain, Neurochem. Int., 52, 256, 10.1016/j.neuint.2007.06.014
Liao, 2005, Local proteins associated with methamphetamine-induced nigrostriatal dopaminergic neurotoxicity, J. Neurochem., 95, 160, 10.1111/j.1471-4159.2005.03346.x
Lin, 1991, Hyperthermia enhances the cytotoxic effects of reactive oxygen species to Chinese hamster cells and bovine endothelial cells in vitro, Radiat. Res., 126, 43, 10.2307/3578169
Lorez, 1981, Fluorescence histochemistry indicates damage of striatal dopamine nerve terminals in rats after multiple doses of methamphetamine, Life Sci., 28, 911, 10.1016/0024-3205(81)90053-9
Lotharius, 2005, Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway, J. Neurosci., 25, 6329, 10.1523/JNEUROSCI.1746-05.2005
Luoma, 2008, Deafferentation-induced activation of NFAT (nuclear factor of activated T-cells) in cochlear nucleus neurons during a developmental critical period: a role for NFATc4-dependent apoptosis in the CNS, J. Neurosci., 28, 3159, 10.1523/JNEUROSCI.5227-07.2008
Lynch, 1992, Cardiovascular effects of methamphetamine, J. Cardiovasc. Nurs., 6, 12, 10.1097/00005082-199201000-00004
Malemud, 2008, Pro-inflammatory cytokine-induced SAPK/MAPK and JAK/STAT in rheumatoid arthritis and the new anti-depression drugs, Expert Opin. Ther. Targets, 12, 171, 10.1517/14728222.12.2.171
Maragos, 2000, Methamphetamine toxicity is attenuated in mice that overexpress human manganese superoxide dismutase, Brain Res., 878, 218, 10.1016/S0006-8993(00)02707-4
Marciniak, 2006, Endoplasmic reticulum stress signaling in disease, Physiol. Rev., 86, 1133, 10.1152/physrev.00015.2006
Marek, 1990, Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons, Brain Res., 513, 274, 10.1016/0006-8993(90)90467-P
Mark, 2004, High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity, J. Neurosci., 24, 11449, 10.1523/JNEUROSCI.3597-04.2004
Mark, 2007, Dynamic changes in vesicular glutamate transporter 1 function and expression related to methamphetamine-induced glutamate release, J. Neurosci., 27, 6823, 10.1523/JNEUROSCI.0013-07.2007
Marshall, 1993, Dopamine–glutamate interactions in methamphetamine-induced neurotoxicity, J. Neural. Transm. Gen. Sect., 91, 241, 10.1007/BF01245234
Maxwell, 2008, The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992–2007, Drug Alcohol Rev., 27, 229, 10.1080/09595230801919460
McCann, 1998, Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428, J. Neurosci., 18, 8417, 10.1523/JNEUROSCI.18-20-08417.1998
McCann, 2008, Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users, Synapse, 62, 91, 10.1002/syn.20471
Melega, 1997, Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey, Brain Res., 766, 113, 10.1016/S0006-8993(97)00548-9
Melega, 2000, Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey, Synapse, 35, 243, 10.1002/(SICI)1098-2396(20000315)35:4<243::AID-SYN1>3.0.CO;2-N
Melega, 2007, Methamphetamine increases basal ganglia iron to levels observed in aging, Neuroreport, 18, 1741, 10.1097/WNR.0b013e3282f0d4f4
Melega, 2008, Long-term methamphetamine administration in the vervet monkey models aspects of a human exposure: brain neurotoxicity and behavioral profiles, Neuropsychopharmacology, 33, 1441, 10.1038/sj.npp.1301502
Meredith, 2005, Implications of chronic methamphetamine use: a literature review, Harv. Rev. Psychiatry, 13, 141, 10.1080/10673220591003605
2007
Miller, 1994, Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse, J. Pharmacol. Exp. Ther., 270, 752
Mirecki, 2004, Brain antioxidant systems in human methamphetamine users, J. Neurochem., 89, 1396, 10.1111/j.1471-4159.2004.02434.x
Miyazaki, 2006, Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone-formation-related molecules, FASEB J., 20, 571, 10.1096/fj.05-4996fje
Montine, 1997, Neurotoxicity of endogenous cysteinylcatechols, Exp. Neurol., 148, 26, 10.1006/exnr.1997.6662
Morgan, 1980, Short-term and long-term effects of methamphetamine on biogenic amine metabolism in extra-striatal dopaminergic nuclei, Neuropharmacology, 19, 989, 10.1016/0028-3908(80)90010-6
Moszczynska, 1998, Rat striatal levels of the antioxidant glutathione are decreased following binge administration of methamphetamine, Neurosci. Lett., 255, 49, 10.1016/S0304-3940(98)00711-3
Moszczynska, 2004, Why is parkinsonism not a feature of human methamphetamine users?, Brain, 127, 363, 10.1093/brain/awh046
Murray, 1998, Psychophysiological aspects of amphetamine–methamphetamine abuse, J. Psychol., 132, 227, 10.1080/00223989809599162
Nakagawa, 2000, Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis, J. Cell Biol., 150, 887, 10.1083/jcb.150.4.887
Nash, 1992, Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine, Brain Res., 581, 237, 10.1016/0006-8993(92)90713-J
Nash, 1988, Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine, J. Pharmacol. Exp. Ther., 245, 873
Numachi, 2007, Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters, Eur. J. Pharmacol., 572, 120, 10.1016/j.ejphar.2007.06.022
O'Callaghan, 1994, Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse, J. Pharmacol. Exp. Ther., 270, 741
O'Dell, 2000, Repeated administration of methamphetamine damages cells in the somatosensory cortex: overlap with cytochrome oxidase-rich barrels, Synapse, 37, 32, 10.1002/(SICI)1098-2396(200007)37:1<32::AID-SYN4>3.0.CO;2-X
O'Dell, 2005, Neurotoxic regimens of methamphetamine induce persistent expression of phospho-c-Jun in somatosensory cortex and substantia nigra, Synapse, 55, 137, 10.1002/syn.20098
O'Dell, 1993, Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists, J. Neurochem., 60, 1792, 10.1111/j.1471-4159.1993.tb13405.x
Ohmori, 1993, Competitive and noncompetitive N-methyl-d-aspartate antagonists protect dopaminergic and serotonergic neurotoxicity produced by methamphetamine in various brain regions, J. Neural Transm. Gen. Sect., 92, 97, 10.1007/BF01244869
Pacher, 2007, Nitric oxide and peroxynitrite in health and disease, Physiol. Rev., 87, 315, 10.1152/physrev.00029.2006
Paulus, 2002, Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects, Neuropsychopharmacology, 26, 53, 10.1016/S0893-133X(01)00334-7
Pennypacker, 2000, Long-term induction of Fos-related antigen-2 after methamphetamine-, methylenedioxymethamphetamine-, 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine- and trimethyltin-induced brain injury, Neuroscience, 101, 913, 10.1016/S0306-4522(00)00381-X
Perez, 1999, Methamphetamine-related stroke: four cases, J. Emerg. Med., 17, 469, 10.1016/S0736-4679(99)00009-8
Perry, 2007, Systemic infections and inflammation affect chronic neurodegeneration, Nat. Rev. Immunol., 7, 161, 10.1038/nri2015
Planas, 2006, Signalling pathways mediating inflammatory responses in brain ischaemia, Biochem. Soc. Trans., 34, 1267, 10.1042/BST0341267
Poli, 2004, Oxidative stress and cell signalling, Curr. Med. Chem., 11, 1163, 10.2174/0929867043365323
Potashkin, 2006, The role of oxidative stress in the dysregulation of gene expression and protein metabolism in neurodegenerative disease, Antioxid. Redox Signal., 8, 144, 10.1089/ars.2006.8.144
Preston, 1985, Methamphetamine, physostigmine, atropine and mecamylamine: effects on force lever performance, Pharmacol. Biochem. Behav., 23, 781, 10.1016/0091-3057(85)90072-3
Preston, 1985, Long-term effects of repeated methylamphetamine administration on monoamine neurons in the rhesus monkey brain, Brain Res., 338, 243, 10.1016/0006-8993(85)90153-2
Pubill, 2002, Carnosine prevents methamphetamine-induced gliosis but not dopamine terminal loss in rats, Eur. J. Pharmacol., 448, 165, 10.1016/S0014-2999(02)01949-0
Pubill, 2003, Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity, Naunyn Schmiedebergs Arch. Pharmacol., 367, 490, 10.1007/s00210-003-0747-y
Pubill, 2005, Free radical production induced by methamphetamine in rat striatal synaptosomes, Toxicol. Appl. Pharmacol., 204, 57, 10.1016/j.taap.2004.08.008
Quinton, 2007, Neurotoxic effects of chronic restraint stress in the striatum of methamphetamine-exposed rats, Psychopharmacology (Berl), 193, 341, 10.1007/s00213-007-0796-x
Raivich, 2005, Like cops on the beat: the active role of resting microglia, Trends Neurosci., 28, 571, 10.1016/j.tins.2005.09.001
Reback, 2008, Methamphetamine use trends among street-recruited gay and bisexual males, from 1999 to 2007, J. Urban Health, 85, 874, 10.1007/s11524-008-9326-3
Ricaurte, 1980, Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study, Brain Res., 193, 153, 10.1016/0006-8993(80)90952-X
Ricaurte, 1982, Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain, Brain Res., 235, 93, 10.1016/0006-8993(82)90198-6
Ricaurte, 1983, Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine, Neuropharmacology, 22, 1165, 10.1016/0028-3908(83)90075-8
Ricaurte, 1984, Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers, Brain Res., 303, 359, 10.1016/0006-8993(84)91221-6
Richards, 1993, A high-dose methamphetamine regimen results in long-lasting deficits on performance of a reaction-time task, Brain Res., 627, 254, 10.1016/0006-8993(93)90328-K
Rippeth, 2004, Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons, J. Int. Neuropsychol. Soc., 10, 1, 10.1017/S1355617704101021
Salo, 2002, Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals, Psychiatry Res., 111, 65, 10.1016/S0165-1781(02)00111-7
Salo, 2007, Attentional control and brain metabolite levels in methamphetamine abusers, Biol. Psychiatry, 61, 1272, 10.1016/j.biopsych.2006.07.031
Samantaray, 2006, Calpain activation in apoptosis of motoneurons in cell culture models of experimental parkinsonism, Ann. N. Y. Acad. Sci., 1074, 349, 10.1196/annals.1369.034
Sanchez, 1989, The effects of dopamine D-1 and D-2 receptor agonists on body temperature in male mice, Eur. J. Pharmacol., 171, 201, 10.1016/0014-2999(89)90108-8
Sanchez, 2003, The nNOS inhibitor, AR-R17477AR, prevents the loss of NF68 immunoreactivity induced by methamphetamine in the mouse striatum, J. Neurochem., 85, 515, 10.1046/j.1471-4159.2003.01714.x
Sandoval, 2003, Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits, J. Pharmacol. Exp. Ther., 304, 1181, 10.1124/jpet.102.045005
Sapp, 2001, Early and progressive accumulation of reactive microglia in the Huntington disease brain, J. Neuropathol. Exp. Neurol., 60, 161, 10.1093/jnen/60.2.161
Schepers, 2003, Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers, Clin. Chem., 49, 121, 10.1373/49.1.121
Schmidt, 1985, Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid, Eur. J. Pharmacol., 109, 73, 10.1016/0014-2999(85)90541-2
Schmidt, 1985, Role of the serotonin uptake carrier in the neurochemical response to methamphetamine: effects of citalopram and chlorimipramine, Neurochem. Res., 10, 637, 10.1007/BF00964403
Schmidt, 1985, Role of dopamine in the neurotoxic effects of methamphetamine, J. Pharmacol. Exp. Ther., 233, 539
Schmidt, 1985, Methamphetamine-induced depression of monoamine synthesis in the rat: development of tolerance, J. Neurochem., 44, 852, 10.1111/j.1471-4159.1985.tb12893.x
Schmued, 1997, Methamphetamine exposure can produce neuronal degeneration in mouse hippocampal remnants, Brain Res., 759, 135, 10.1016/S0006-8993(97)00173-X
Scott, 2007, Neurocognitive effects of methamphetamine: a critical review and meta-analysis, Neuropsychol. Rev., 17, 275, 10.1007/s11065-007-9031-0
Segal, 1997, Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization, J. Pharmacol. Exp. Ther., 282, 561
Segal, 2003, Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge, Neuropsychopharmacology, 28, 1730, 10.1038/sj.npp.1300247
Segal, 2005, Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterization, Psychopharmacology (Berl), 180, 501, 10.1007/s00213-005-2188-4
Seiden, 1976, Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys, Drug Alcohol Depend., 1, 215, 10.1016/0376-8716(76)90030-2
Sekine, 2002, Metabolite alterations in basal ganglia associated with methamphetamine-related psychiatric symptoms. A proton MRS study, Neuropsychopharmacology, 27, 453, 10.1016/S0893-133X(02)00321-4
Sekine, 2003, Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms, Am. J. Psychiatry, 160, 1699, 10.1176/appi.ajp.160.9.1699
Sekine, 2006, Brain serotonin transporter density and aggression in abstinent methamphetamine abusers, Arch. Gen. Psychiatry, 63, 90, 10.1001/archpsyc.63.1.90
Sekine, 2008, Methamphetamine causes microglial activation in the brains of human abusers, J. Neurosci., 28, 5756, 10.1523/JNEUROSCI.1179-08.2008
Semple, 2005, Impulsivity and methamphetamine use, J. Subst. Abuse Treat., 29, 85, 10.1016/j.jsat.2005.05.001
Sharma, 2006, Alterations in blood–brain barrier function by morphine and methamphetamine, Ann. N. Y. Acad. Sci., 1074, 198, 10.1196/annals.1369.020
Sharma, 2009, Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat: an experimental study using light and electron microscopy, J. Chem. Neuroanat., 37, 18, 10.1016/j.jchemneu.2008.08.002
Sharma, 2007, Drugs of abuse-induced hyperthermia, blood–brain barrier dysfunction and neurotoxicity: neuroprotective effects of a new antioxidant compound H-290/51, Curr. Pharm. Des., 13, 1903, 10.2174/138161207780858375
Sheng, 1996, Nitric oxide is a mediator of methamphetamine (METH)-induced neurotoxicity. In vitro evidence from primary cultures of mesencephalic cells, Ann. N. Y. Acad. Sci., 801, 174, 10.1111/j.1749-6632.1996.tb17440.x
Shioda, 2007, Constitutively active calcineurin mediates delayed neuronal death through Fas-ligand expression via activation of NFAT and FKHR transcriptional activities in mouse brain ischemia, J. Neurochem., 102, 1506, 10.1111/j.1471-4159.2007.04600.x
Shoptaw, 2007, Methamphetamine use and infectious disease-related behaviors in men who have sex with men: implications for interventions, Addiction, 102, 130, 10.1111/j.1360-0443.2006.01775.x
Sim, 2002, Cognitive deficits among methamphetamine users with attention deficit hyperactivity disorder symptomatology, J. Addict. Dis., 21, 75, 10.1300/J069v21n01_07
Simon, 2002, Cognitive performance of current methamphetamine and cocaine abusers, J. Addict. Dis., 21, 61, 10.1300/J069v21n01_06
Simon, 2004, The effect of relapse on cognition in abstinent methamphetamine abusers, J. Subst. Abuse Treat., 27, 59, 10.1016/j.jsat.2004.03.011
Sonsalla, 1986, Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems, J. Pharmacol. Exp. Ther., 238, 932
Sonsalla, 1989, Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity, Science, 243, 398, 10.1126/science.2563176
Sonsalla, 1991, Competitive and noncompetitive antagonists at N-methyl-d-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice, J. Pharmacol. Exp. Ther., 256, 506
Sonsalla, 1998, Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism, Amino Acids, 14, 69, 10.1007/BF01345245
Spencer, 2002, 5-s-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons, J. Neurochem., 81, 122, 10.1046/j.1471-4159.2002.00808.x
Sprague, 2004, UCP3 and thyroid hormone involvement in methamphetamine-induced hyperthermia, Biochem. Pharmacol., 68, 1339, 10.1016/j.bcp.2004.03.049
Sriram, 2006, Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha, J. Neurochem., 96, 706, 10.1111/j.1471-4159.2005.03566.x
Staszewski, 2006, Methamphetamine-induced spectrin proteolysis in the rat striatum, J. Neurochem., 96, 1267, 10.1111/j.1471-4159.2005.03618.x
Stephans, 1994, Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux, Synapse, 17, 203, 10.1002/syn.890170310
Stephans, 1996, Methamphetamines pretreatment and the vulnerability of the striatum to methamphetamine neurotoxicity, Neuroscience, 72, 593, 10.1016/0306-4522(95)00587-0
Stokes, 1999, Cytotoxic and genotoxic potential of dopamine, J. Neurosci. Res., 55, 659, 10.1002/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C
Stone, 1989, Acute inactivation of tryptophan hydroxylase by amphetamine analogs involves the oxidation of sulfhydryl sites, Eur. J. Pharmacol., 172, 93, 10.1016/0922-4106(89)90048-5
Straiko, 2007, The effect of amphetamine analogs on cleaved microtubule-associated protein-tau formation in the rat brain, Neuroscience, 144, 223, 10.1016/j.neuroscience.2006.08.073
2007
Sulzer, 2005, Mechanisms of neurotransmitter release by amphetamines: a review, Prog. Neurobiol., 75, 406, 10.1016/j.pneurobio.2005.04.003
Sung, 2007, Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study, Drug Alcohol Depend., 88, 28, 10.1016/j.drugalcdep.2006.09.011
Tata, 2008, Chronic stress enhances methamphetamine-induced extracellular glutamate and excitotoxicity in the rat striatum, Synapse, 62, 325, 10.1002/syn.20497
Tata, 2007, Augmentation of methamphetamine-induced toxicity in the rat striatum by unpredictable stress: contribution of enhanced hyperthermia, Eur. J. Neurosci., 26, 739, 10.1111/j.1460-9568.2007.05688.x
Taylor, 2007, Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy, J. Neurovirol., 13, 150, 10.1080/13550280701194230
Thiriet, 2005, Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum, J. Neurosci., 25, 5273, 10.1523/JNEUROSCI.4893-04.2005
Thomas, 2005, Attenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine, J. Neurochem., 92, 790, 10.1111/j.1471-4159.2004.02906.x
Thomas, 2005, MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity, Brain Res., 1050, 190, 10.1016/j.brainres.2005.05.049
Thomas, 2004, Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines, Neurosci. Lett., 367, 349, 10.1016/j.neulet.2004.06.065
Thomas, 2004, Identification of differentially regulated transcripts in mouse striatum following methamphetamine treatment—an oligonucleotide microarray approach, J. Neurochem., 88, 380, 10.1046/j.1471-4159.2003.02182.x
Thomas, 2004, Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation, J. Pharmacol. Exp. Ther., 311, 1, 10.1124/jpet.104.070961
Thomas, 2008, The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity, J. Neurochem., 105, 605, 10.1111/j.1471-4159.2007.05155.x
Thompson, 2004, Structural abnormalities in the brains of human subjects who use methamphetamine, J. Neurosci., 24, 6028, 10.1523/JNEUROSCI.0713-04.2004
Thorburn, 2004, Death receptor-induced cell killing, Cell Signal, 16, 139, 10.1016/j.cellsig.2003.08.007
Toth, 2001, Activation-induced apoptosis and cell surface expression of Fas (CD95) ligand are reciprocally regulated by retinoic acid receptor alpha and gamma and involve nur77 in T cells, Eur. J. Immunol., 31, 1382, 10.1002/1521-4141(200105)31:5<1382::AID-IMMU1382>3.0.CO;2-Y
Truong, 2005, Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity, J. Pharmacol. Exp. Ther., 314, 1087, 10.1124/jpet.105.085951
Uemura, 2003, Protein kinase C-epsilon protects PC12 cells against methamphetamine-induced death: possible involvement of suppression of glutamate receptor, Life Sci., 72, 1595, 10.1016/S0024-3205(02)02450-5
2007
Verdejo-Garcia, 2006, Executive dysfunction in substance dependent individuals during drug use and abstinence: an examination of the behavioral, cognitive and emotional correlates of addiction, J. Int. Neuropsychol. Soc., 12, 405, 10.1017/S1355617706060486
Verma, 1993, Differential role of dopamine receptor subtypes in thermoregulation and stereotypic behavior in naive and reserpinized rats, Arch. Int. Pharmacodyn. Ther., 324, 17
Villemagne, 1998, Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations, J. Neurosci., 18, 419, 10.1523/JNEUROSCI.18-01-00419.1998
Volkow, 2001, Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence, J. Neurosci., 21, 9414, 10.1523/JNEUROSCI.21-23-09414.2001
Volkow, 2001, Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers, Am. J. Psychiatry, 158, 383, 10.1176/appi.ajp.158.3.383
Volkow, 2001, Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers, Am. J. Psychiatry, 158, 377, 10.1176/appi.ajp.158.3.377
Wagner, 1991, Evaluation of the effects of inhibition of monoamine oxidase and senescence on methamphetamine-induced neuronal damage, Int. J. Dev. Neurosci., 9, 171, 10.1016/0736-5748(91)90008-A
Wagner, 1979, Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs, Drug Alcohol Depend., 4, 435, 10.1016/0376-8716(79)90076-0
Wagner, 1980, Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine, Brain Res., 181, 151, 10.1016/0006-8993(80)91265-2
Wagner, 1983, Alpha-methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes, Brain Res., 270, 285, 10.1016/0006-8993(83)90602-9
Wagner, 1985, Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats, Res. Commun. Chem. Pathol. Pharmacol., 47, 221
Wallace, 2005, A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine, Annu. Rev. Genet., 39, 359, 10.1146/annurev.genet.39.110304.095751
Wallace, 2003, Methamphetamine enhances the cleavage of the cytoskeletal protein tau in the rat brain, Neuroscience, 116, 1063, 10.1016/S0306-4522(02)00795-9
Walsh, 1992, Motor impairments after methamphetamine-induced neurotoxicity in the rat, J. Pharmacol. Exp. Ther., 263, 617
Wang, 2004, Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence, Am. J. Psychiatry, 161, 242, 10.1176/appi.ajp.161.2.242
Wang, 2008, Involvement of oxidative stress-activated JNK signaling in the methamphetamine-induced cell death of human SH-SY5Y cells, Toxicology, 246, 234, 10.1016/j.tox.2008.01.020
Warren, 2005, Concurrent calpain and caspase-3 mediated proteolysis of alpha II-spectrin and tau in rat brain after methamphetamine exposure: a similar profile to traumatic brain injury, Life Sci., 78, 301, 10.1016/j.lfs.2005.04.058
Warren, 2007, Calpain and caspase proteolytic markers co-localize with rat cortical neurons after exposure to methamphetamine and MDMA, Acta Neuropathol., 114, 277, 10.1007/s00401-007-0259-9
Warren, 2007, Calpain- and caspase-mediated alphaII-spectrin and tau proteolysis in rat cerebrocortical neuronal cultures after ecstasy or methamphetamine exposure, Int. J. Neuropsychopharmacol., 10, 479, 10.1017/S1461145706007061
Weihmuller, 1992, MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow, Synapse, 11, 155, 10.1002/syn.890110209
Weihmuller, 1993, L-dopa pretreatment potentiates striatal dopamine overflow and produces dopamine terminal injury after a single methamphetamine injection, Brain Res., 623, 303, 10.1016/0006-8993(93)91442-U
Whitehead, 2001, Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter, J. Neurochem., 76, 1242, 10.1046/j.1471-4159.2001.00125.x
Wilson, 1996, Striatal dopamine nerve terminal markers in human, chronic methamphetamine users, Nat. Med., 2, 699, 10.1038/nm0696-699
Woods, 2005, Deficient strategic control of verbal encoding and retrieval in individuals with methamphetamine dependence, Neuropsychology, 19, 35, 10.1037/0894-4105.19.1.35
Woolverton, 1989, Long-term effects of chronic methamphetamine administration in rhesus monkeys, Brain Res., 486, 73, 10.1016/0006-8993(89)91279-1
Wu, 2007, Enhanced oxidative stress and aberrant mitochondrial biogenesis in human neuroblastoma SH-SY5Y cells during methamphetamine induced apoptosis, Toxicol. Appl. Pharmacol., 220, 243, 10.1016/j.taap.2007.01.011
Xiang, 2006, Microglia activation in the brain as inflammatory biomarker of Alzheimer's disease neuropathology and clinical dementia, Dis. Markers, 22, 95, 10.1155/2006/276239
Xie, 2000, Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity, J. Neurosci., 20, 7838, 10.1523/JNEUROSCI.20-20-07838.2000
Xu, 2005, Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors, Synapse, 58, 110, 10.1002/syn.20185
Yamaguchi, 1991, Methamphetamine-induced expression of interleukin-1 beta mRNA in the rat hypothalamus, Neurosci. Lett., 128, 90, 10.1016/0304-3940(91)90766-M
Yamamoto, 2005, Amphetamine neurotoxicity: cause and consequence of oxidative stress, Crit. Rev. Neurobiol., 17, 87, 10.1615/CritRevNeurobiol.v17.i2.30
Yen, 1994, Stroke associated with methamphetamine inhalation, Eur. Neurol., 34, 16, 10.1159/000117002
Yorimitsu, 2005, Autophagy: molecular machinery for self-eating, Cell Death Differ., 12, 1542, 10.1038/sj.cdd.4401765
Yoshizumi, 2000, Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species, J. Biol. Chem., 275, 11706, 10.1074/jbc.275.16.11706
Yuan, 2006, Relationship between temperature, dopaminergic neurotoxicity, and plasma drug concentrations in methamphetamine-treated squirrel monkeys, J. Pharmacol. Exp. Ther., 316, 1210, 10.1124/jpet.105.096503
Zafar, 2006, A potential role for cyclized quinones derived from dopamine, DOPA, and 3,4-dihydroxyphenylacetic acid in proteasomal inhibition, Mol. Pharmacol., 70, 1079, 10.1124/mol.106.024703
Zarrindast, 1992, Involvement of dopamine receptor subtypes in mouse thermoregulation, Psychopharmacology (Berl), 107, 341, 10.1007/BF02245159
Zhang, 2006, Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine, Prog. Neuropsychopharmacol. Biol. Psychiatry, 30, 1381, 10.1016/j.pnpbp.2006.05.015
Zhao, 2007, General versus specific actions of mild-moderate hypothermia in attenuating cerebral ischemic damage, J. Cereb. Blood Flow Metab., 27, 1879, 10.1038/sj.jcbfm.9600540
Zhu, 2005, Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice, Brain Res., 1049, 171, 10.1016/j.brainres.2005.04.089
Zhu, 2006, Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice, Neuroscience, 140, 607, 10.1016/j.neuroscience.2006.02.055
Zhu, 2006, Methamphetamine-induced striatal apoptosis in the mouse brain: comparison of a binge to an acute bolus drug administration, Neurotoxicology, 27, 131, 10.1016/j.neuro.2005.05.014